Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)

SHA:603811 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	191.03	220.7	173.04	294.14	213.51	83.32
Cash & Short-Term Investments	206.03	220.7	173.04	294.14	213.51	83.32
Cash Growth	0.44%	27.55%	-41.17%	37.77%	156.25%	15.23%
Accounts Receivable	29.09	38.96	72.91	93.18	90.44	78.79
Other Receivables	1.83	1.56	6.47	2.87	1.28	1.33
Receivables	30.92	40.52	79.38	96.05	91.72	80.12
Inventory	131.82	116.34	131.84	116.78	111.04	117
Other Current Assets	87.42	17.92	9.36	10.45	20.57	7.35
Total Current Assets	456.19	395.49	393.62	517.42	436.84	287.8
Property, Plant & Equipment	898.39	891.23	945.69	1,003	919.65	668.66
Long-Term Investments	338.89	336.72	314.87	281.13	234.01	208.2
Goodwill	-	-	-	-	-	2.42
Other Intangible Assets	51.64	53.02	63.95	66.66	68.45	70.19
Long-Term Deferred Tax Assets	7.66	8	6.3	5.94	17.47	5.16
Long-Term Deferred Charges	0.22	0.2	0.41	1.43	1.44	2.24
Other Long-Term Assets	22.05	17.7	3.55	17.55	41.24	77.83
Total Assets	1,775	1,702	1,728	1,893	1,719	1,322

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	54.44	53.69	84.67	118.91	54.79	57.5
Accrued Expenses	12.93	131.87	78.28	76.15	79.75	72.57
Short-Term Debt	19.91	15.01	51.1	117.33	76.5	86.36
Current Portion of Long-Term Debt	9.81	17.04	40.43	8.91	14.02	-
Current Portion of Leases	-	-	0.02	0.75	0.61	0.76
Current Income Taxes Payable	11.25	13.87	6.4	-	-	7.83
Current Unearned Revenue	17.69	7.59	12.22	4.38	13.74	6.11
Other Current Liabilities	93.43	27.25	18.38	16.22	18.59	15.75
Total Current Liabilities	219.46	266.33	291.5	342.65	257.99	246.87
Long-Term Debt	25	5.7	139.31	316.38	334.77	59.63
Long-Term Leases	-	-	-	0.47	0.91	1.79
Long-Term Unearned Revenue	19.33	20.42	18.77	21.29	16.93	12.22
Long-Term Deferred Tax Liabilities	10.88	12.1	13.74	15.37	17.56	3.11
Total Liabilities	274.66	304.55	463.31	696.15	628.16	323.62

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	458.23	327.3	327.3	327.3	233.79	233.79
Additional Paid-In Capital	50.1	138.71	143	143	236.51	238.08
Retained Earnings	1,012	972.74	857.04	721.8	617.36	514.22
Treasury Stock	-28.97	-48.29	-67.26	-	-	-
Comprehensive Income & Other	-	-	-	0.21	0.23	0.22
Total Common Equity	1,492	1,390	1,260	1,192	1,088	986.31
Minority Interest	8.64	7.33	4.98	4.3	3.05	12.57
Shareholders' Equity	1,500	1,398	1,265	1,197	1,091	998.88
Total Liabilities & Equity	1,775	1,702	1,728	1,893	1,719	1,322

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	54.72	37.75	230.86	443.84	426.8	148.54
Net Cash (Debt)	151.31	182.95	-57.82	-149.7	-213.3	-65.22
Net Cash Growth	71.25%	-	-	-	-	-
Net Cash Per Share	0.33	0.41	-0.13	-0.33	-0.46	-0.14
Filing Date Shares Outstanding	464.14	444.76	446.45	458.23	458.23	458.23
Total Common Shares Outstanding	464.14	444.76	446.45	458.23	458.23	458.23
Working Capital	236.74	129.16	102.12	174.78	178.85	40.93
Book Value Per Share	3.21	3.13	2.82	2.60	2.37	2.15
Tangible Book Value	1,440	1,337	1,196	1,126	1,019	913.7
Tangible Book Value Per Share	3.10	3.01	2.68	2.46	2.22	1.99
Buildings	-	656.16	656.07	686.92	441.63	374.71
Machinery	-	681.75	672.02	687.58	600.01	443.66
Construction In Progress	-	30.71	5.15	6.16	182.6	99.91

Data Source: S&P Global Market Intelligence Last updated: Oct 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error